C-Met-IN-18, an ATP-competitive type-III inhibitor, targets both wild-type (WT) and D1228V mutant c-MET with IC50 values of 0.013 µM and 0.20 µM, respectively. It is utilized in research pertaining to c-MET-driven cancers [1].
Molecular Weight:
374.37
Formula:
C21H15FN4O2
Target:
c-Met/HGFR
* VAT and and shipping costs not included. Errors and price changes excepted
